Why the study?
PFO is implicated in multiple medical conditions, but official guidance had previously addressed only left circulation thromboembolism.
This interdisciplinary position paper provides evidence-based statements for managing patent foramen ovale in clinical scenarios beyond left circulation thromboembolism, such as decompression sickness and migraine.
Answers are grounded in this paper and cite their sources.
May warrant individualized PFO closure consideration in select cases; extends guidelines while leaving evidence gaps open.
Patent foramen ovale (PFO) is implicated in the pathogenesis of a number of medical conditions but to date only one official position paper related to left circulation thromboembolism has been published. This interdisciplinary paper, prepared with the involvement of eight European scientific societies, reviews the available evidence and proposes a rationale for decision making for other PFO-related clinical conditions. In order to guarantee a strict evidence-based process, we used a modified grading of recommendations, assessment, development, and evaluation (GRADE) methodology. A critical qualitative and quantitative evaluation of diagnostic and therapeutic procedures was performed, including assessment of the risk/benefit ratio. The level of evidence and the strength of the position statements were weighed and graded according to predefined scales. Despite being based on limited and observational or low-certainty randomised data, a number of position statements were made to frame PFO management in different clinical settings, along with suggestions for new research avenues. This interdisciplinary position paper, recognising the low or very low certainty of existing evidence, provides the first approach to several PFO-related clinical scenarios beyond left circulation thromboembolism and strongly stresses the need for fresh high-quality evidence on these topics.
No takes yet. Share an insight, caveat, or question.
Pristipino et al. (2021) conducted a review in Patent foramen ovale (PFO) with decompression sickness, migraine, or arterial deoxygenation syndromes. Percutaneous PFO closure vs. Medical therapy or behavioral avoidance was evaluated. Percutaneous closure of patent foramen ovale may be considered for select patients with decompression sickness, migraine with aura, or arterial deoxygenation syndromes, though evidence certainty remains low.
Synapse has enriched 10 related papers. Consider them for comparative context: